Insider Purchase: Chief Medical Officer of $BIVI Buys 4,843 Shares

By: Quiver InsiderRadar, Automated

Posted: 15 hours ago / Aug. 29, 2026 1:16 a.m. UTC

Joseph M Palumbo, the Chief Medical Officer of $BIVI, bought 4,843 shares of the company on 08-28-2026 for an estimated $10,460. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 406.0%. Following this trade, they now own 6,036 shares of this class of $BIVI stock.

$BIVI Insider Trading Activity

$BIVI insiders have traded $BIVI stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $BIVI stock by insiders over the last 6 months:

• CUONG V DO (President & CEO) purchased 15,210 shares for an estimated $31,636
• JOSEPH M PALUMBO (Chief Medical Officer) purchased 4,843 shares for an estimated $10,460
• JOANNE WENDY KIM (Chief Financial Officer) purchased 2,500 shares for an estimated $5,450
• AMY SUZON CHAPPELL purchased 727 shares for an estimated $1,570

To track insider transactions, check out Quiver Quantitative’s insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$BIVI Hedge Fund Activity

We have seen 15 institutional investors add shares of $BIVI stock to their portfolio, and 19 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• MORGAN STANLEY added 530,250 shares (+704.9%) to their portfolio in Q2 2026, for an estimated $1,028,685
• DRW SECURITIES, LLC removed 128,356 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $179,698
• DIAMETRIC CAPITAL, LP removed 113,364 shares (-30.6%) from their portfolio in Q2 2026, for an estimated $219,926
• RENAISSANCE TECHNOLOGIES LLC added 60,000 shares (+88.3%) to their portfolio in Q2 2026, for an estimated $116,400
• PRELUDE CAPITAL MANAGEMENT, LLC removed 59,480 shares (-64.6%) from their portfolio in Q2 2026, for an estimated $115,391
• CITADEL ADVISORS LLC added 50,660 shares (+111.9%) to their portfolio in Q2 2026, for an estimated $98,280
• PHILADELPHIA TRUST CO removed 25,000 shares (-33.3%) from their portfolio in Q2 2026, for an estimated $48,500

To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative’s disclaimers for more information.